Victor Ling
WikiDoc Resources for Victor Ling |
Articles |
---|
Most recent articles on Victor Ling Most cited articles on Victor Ling |
Media |
Powerpoint slides on Victor Ling |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Victor Ling at Clinical Trials.gov Clinical Trials on Victor Ling at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Victor Ling
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Victor Ling Discussion groups on Victor Ling Patient Handouts on Victor Ling Directions to Hospitals Treating Victor Ling Risk calculators and risk factors for Victor Ling
|
Healthcare Provider Resources |
Causes & Risk Factors for Victor Ling |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Dr. Victor Ling is an award-winning Canadian researcher in the field of medicine. Ling's research focuses on drug resistance in cancer. He is best known for his discovery of P-glycoprotein, one of the proteins responsible for multidrug resistance.
Ling was born in China, and emigrated to Canada as a child. He received his bachelor's degree in 1966 from the University of Toronto and his PhD in 1969 from the University of British Columbia. In 2006, he was awarded an honorary doctorate from Trinity Western University. He undertook post-doctoral training with nobel-laureate Dr. Fred Sanger at Cambridge University. Ling is currently Assistant Dean of the Faculty of Medicine at the University of British Columbia and Vice-President, Discovery at the BC Cancer Agency in Vancouver, British Columbia.
Honours
- 1990, awarded the Gairdner Award from the Gairdner Foundation for outstanding contributions to medical science
- 1991, awarded the Charles F. Kettering Prize
- 1991, awarded the Steiner Award, the highest honour in cancer research
- 1994, awarded the Robert L. Noble Prize by the National Cancer Institute of Canada
- 2000, appointed to the Order of British Columbia